https://stock.noler.com/us/stock/imrx https://stock.noler.com/us/stock/imrx/13f-holdings https://stock.noler.com/us/stock/imrx/accounts-payable https://stock.noler.com/us/stock/imrx/accounts-receivable https://stock.noler.com/us/stock/imrx/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/imrx/accrued-employee-benefits-current https://stock.noler.com/us/stock/imrx/accrued-employee-benefits-current-and-noncurrent https://stock.noler.com/us/stock/imrx/accrued-liabilities-current https://stock.noler.com/us/stock/imrx/accrued-professional-fees-current https://stock.noler.com/us/stock/imrx/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/imrx/accumulated-depreciation https://stock.noler.com/us/stock/imrx/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/imrx/activist-13d-13g https://stock.noler.com/us/stock/imrx/additional-paid-in-capital https://stock.noler.com/us/stock/imrx/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/imrx/allowance-for-doubtful-accounts-premiums-and-other-receivables https://stock.noler.com/us/stock/imrx/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/imrx/amended-reports-10-k https://stock.noler.com/us/stock/imrx/amortization https://stock.noler.com/us/stock/imrx/analyst-ratings-buy https://stock.noler.com/us/stock/imrx/analyst-ratings-hold https://stock.noler.com/us/stock/imrx/analyst-ratings-no-rating https://stock.noler.com/us/stock/imrx/analyst-ratings-sell https://stock.noler.com/us/stock/imrx/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/imrx/aoci https://stock.noler.com/us/stock/imrx/assets-fair-value-disclosure https://stock.noler.com/us/stock/imrx/auditor https://stock.noler.com/us/stock/imrx/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/imrx/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/imrx/available-for-sale-debt-amortized-cost-after-allowance-for-credit-loss https://stock.noler.com/us/stock/imrx/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/imrx/available-for-sale-debt-amortized-cost-current https://stock.noler.com/us/stock/imrx/available-for-sale-debt-amortized-cost-excluding-accrued-interest-before-allowance-for-credit-loss https://stock.noler.com/us/stock/imrx/available-for-sale-debt-current https://stock.noler.com/us/stock/imrx/available-for-sale-debt-excluding-accrued-interest https://stock.noler.com/us/stock/imrx/available-for-sale-debt-excluding-accrued-interest-allowance-for-credit-loss-not-previously-recorded https://stock.noler.com/us/stock/imrx/available-for-sale-debt-excluding-accrued-interest-current https://stock.noler.com/us/stock/imrx/available-for-sale-debt-excluding-accrued-interest-noncurrent https://stock.noler.com/us/stock/imrx/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/imrx/available-for-sale-debt-securities https://stock.noler.com/us/stock/imrx/basic-shares https://stock.noler.com/us/stock/imrx/business https://stock.noler.com/us/stock/imrx/buybacks https://stock.noler.com/us/stock/imrx/capital-expenditures https://stock.noler.com/us/stock/imrx/cash-acquired-in-excess-of-payments-to-acquire-business https://stock.noler.com/us/stock/imrx/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/imrx/cash-and-equivalents https://stock.noler.com/us/stock/imrx/cash-and-restricted-cash https://stock.noler.com/us/stock/imrx/cash-flow-breakdown https://stock.noler.com/us/stock/imrx/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/imrx/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/imrx/clinical-trials https://stock.noler.com/us/stock/imrx/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/imrx/company-guidance https://stock.noler.com/us/stock/imrx/company-profile https://stock.noler.com/us/stock/imrx/comprehensive-income https://stock.noler.com/us/stock/imrx/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/imrx/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/imrx/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/imrx/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/imrx/convertible-securities-retired https://stock.noler.com/us/stock/imrx/cost-of-revenue https://stock.noler.com/us/stock/imrx/cover-page-shares-outstanding https://stock.noler.com/us/stock/imrx/current-assets https://stock.noler.com/us/stock/imrx/current-liabilities https://stock.noler.com/us/stock/imrx/current-ratio https://stock.noler.com/us/stock/imrx/debt-equity-ratio https://stock.noler.com/us/stock/imrx/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/imrx/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/imrx/deferred-income-tax-liabilities https://stock.noler.com/us/stock/imrx/deferred-offering-costs https://stock.noler.com/us/stock/imrx/deferred-tax-assets-gross https://stock.noler.com/us/stock/imrx/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/imrx/deferred-tax-assets-net https://stock.noler.com/us/stock/imrx/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/imrx/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/imrx/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/imrx/deferred-tax-assets-unrealized-currency-losses https://stock.noler.com/us/stock/imrx/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/imrx/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/imrx/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/imrx/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/imrx/deferred-tax-liabilities-unrealized-gains-on-trading-securities https://stock.noler.com/us/stock/imrx/depreciation https://stock.noler.com/us/stock/imrx/depreciation-and-amortization https://stock.noler.com/us/stock/imrx/diluted-shares https://stock.noler.com/us/stock/imrx/dividend https://stock.noler.com/us/stock/imrx/dividend-safety https://stock.noler.com/us/stock/imrx/dividends-preferred-stock https://stock.noler.com/us/stock/imrx/ebitda https://stock.noler.com/us/stock/imrx/ebitda-margin https://stock.noler.com/us/stock/imrx/effective-tax-rate https://stock.noler.com/us/stock/imrx/employee-count https://stock.noler.com/us/stock/imrx/eps https://stock.noler.com/us/stock/imrx/eps-basic https://stock.noler.com/us/stock/imrx/executive-pay-pvp https://stock.noler.com/us/stock/imrx/executive-salary-officers https://stock.noler.com/us/stock/imrx/expense-breakdown https://stock.noler.com/us/stock/imrx/financing-cash-flow https://stock.noler.com/us/stock/imrx/financing-receivable-allowance-for-credit-losses https://stock.noler.com/us/stock/imrx/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/imrx/form-144-stocks https://stock.noler.com/us/stock/imrx/form-n-port-stocks https://stock.noler.com/us/stock/imrx/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/imrx/general-and-administrative-expense https://stock.noler.com/us/stock/imrx/goodwill https://stock.noler.com/us/stock/imrx/goodwill-impairment-loss https://stock.noler.com/us/stock/imrx/graph https://stock.noler.com/us/stock/imrx/gross-margin https://stock.noler.com/us/stock/imrx/gross-profit https://stock.noler.com/us/stock/imrx/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/imrx/impairment-of-investments https://stock.noler.com/us/stock/imrx/included-in-etf https://stock.noler.com/us/stock/imrx/income-tax https://stock.noler.com/us/stock/imrx/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/imrx/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/imrx/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/imrx/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/imrx/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/imrx/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/imrx/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/imrx/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/imrx/insider-transactions https://stock.noler.com/us/stock/imrx/investing-cash-flow https://stock.noler.com/us/stock/imrx/investment-income-interest https://stock.noler.com/us/stock/imrx/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/imrx/iran-activity-notices-irannotice https://stock.noler.com/us/stock/imrx/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/imrx/lease-cost https://stock.noler.com/us/stock/imrx/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/imrx/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/imrx/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/imrx/level-3-asset-transfers-net https://stock.noler.com/us/stock/imrx/level-3-liability-transfers-net https://stock.noler.com/us/stock/imrx/market-cap https://stock.noler.com/us/stock/imrx/marketable-securities https://stock.noler.com/us/stock/imrx/marketable-securities-current https://stock.noler.com/us/stock/imrx/marketable-securities-noncurrent https://stock.noler.com/us/stock/imrx/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/imrx/material-contracts https://stock.noler.com/us/stock/imrx/net-change-in-cash https://stock.noler.com/us/stock/imrx/net-income https://stock.noler.com/us/stock/imrx/net-margin https://stock.noler.com/us/stock/imrx/news https://stock.noler.com/us/stock/imrx/number-of-operating-segments https://stock.noler.com/us/stock/imrx/number-of-reportable-segments https://stock.noler.com/us/stock/imrx/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/imrx/oci-net-of-tax https://stock.noler.com/us/stock/imrx/oci-net-of-tax-2 https://stock.noler.com/us/stock/imrx/operating-cash-flow https://stock.noler.com/us/stock/imrx/operating-expenses https://stock.noler.com/us/stock/imrx/operating-income https://stock.noler.com/us/stock/imrx/operating-lease-assets https://stock.noler.com/us/stock/imrx/operating-lease-cost https://stock.noler.com/us/stock/imrx/operating-lease-liability https://stock.noler.com/us/stock/imrx/operating-lease-liability-current https://stock.noler.com/us/stock/imrx/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/imrx/operating-lease-payments https://stock.noler.com/us/stock/imrx/operating-lease-payments-due https://stock.noler.com/us/stock/imrx/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/imrx/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/imrx/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/imrx/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/imrx/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/imrx/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/imrx/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/imrx/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/imrx/operating-margin https://stock.noler.com/us/stock/imrx/options-activity https://stock.noler.com/us/stock/imrx/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/imrx/other-current-liabilities https://stock.noler.com/us/stock/imrx/other-noncurrent-assets https://stock.noler.com/us/stock/imrx/other-noncurrent-liabilities https://stock.noler.com/us/stock/imrx/other-nonoperating-income-expense https://stock.noler.com/us/stock/imrx/other-sundry-liabilities-current https://stock.noler.com/us/stock/imrx/other-than-temporary-impairment-loss-debt-securities-portion-recognized-in-earnings https://stock.noler.com/us/stock/imrx/outstanding-bonds https://stock.noler.com/us/stock/imrx/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/imrx/patents-active https://stock.noler.com/us/stock/imrx/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/imrx/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/imrx/pb-ratio https://stock.noler.com/us/stock/imrx/pe-ratio https://stock.noler.com/us/stock/imrx/pre-tax-margin https://stock.noler.com/us/stock/imrx/preferred-shares-facts https://stock.noler.com/us/stock/imrx/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/imrx/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/imrx/preferred-stock-shares-authorized https://stock.noler.com/us/stock/imrx/preferred-stock-shares-issued https://stock.noler.com/us/stock/imrx/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/imrx/preferred-stock-value https://stock.noler.com/us/stock/imrx/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/imrx/pretax-income https://stock.noler.com/us/stock/imrx/previous-etf-holding-it https://stock.noler.com/us/stock/imrx/price-fcf-ratio https://stock.noler.com/us/stock/imrx/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/imrx/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/imrx/proceeds-from-stock-issued https://stock.noler.com/us/stock/imrx/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/imrx/proceeds-from-stock-plans https://stock.noler.com/us/stock/imrx/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/imrx/profit-breakdown https://stock.noler.com/us/stock/imrx/property-plant-and-equipment-gross https://stock.noler.com/us/stock/imrx/property-plant-equipment https://stock.noler.com/us/stock/imrx/ps-ratio https://stock.noler.com/us/stock/imrx/public-float https://stock.noler.com/us/stock/imrx/quick-ratio https://stock.noler.com/us/stock/imrx/realized-gains-on-securities https://stock.noler.com/us/stock/imrx/research-and-development https://stock.noler.com/us/stock/imrx/retained-earnings https://stock.noler.com/us/stock/imrx/return-on-tangible-equity https://stock.noler.com/us/stock/imrx/revenue https://stock.noler.com/us/stock/imrx/revenue-breakdown https://stock.noler.com/us/stock/imrx/roa https://stock.noler.com/us/stock/imrx/roe https://stock.noler.com/us/stock/imrx/roi https://stock.noler.com/us/stock/imrx/scorecard https://stock.noler.com/us/stock/imrx/sec-comment-letters-upload https://stock.noler.com/us/stock/imrx/sec-enforcement-actions https://stock.noler.com/us/stock/imrx/sec-filings-10-q https://stock.noler.com/us/stock/imrx/sec-filings-25-nse https://stock.noler.com/us/stock/imrx/sec-filings-8-k https://stock.noler.com/us/stock/imrx/sec-filings-px14a6g https://stock.noler.com/us/stock/imrx/sec-filings-s-4 https://stock.noler.com/us/stock/imrx/secondary-offerings https://stock.noler.com/us/stock/imrx/shareholders-equity https://stock.noler.com/us/stock/imrx/shares-outstanding https://stock.noler.com/us/stock/imrx/short-sale-volume https://stock.noler.com/us/stock/imrx/short-term-lease-cost https://stock.noler.com/us/stock/imrx/short-term-lease-payments https://stock.noler.com/us/stock/imrx/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/imrx/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/imrx/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/imrx/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/imrx/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/imrx/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/imrx/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/imrx/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/imrx/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/imrx/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/imrx/stock-based-compensation https://stock.noler.com/us/stock/imrx/stock-issued-new-shares-sold https://stock.noler.com/us/stock/imrx/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/imrx/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/imrx/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/imrx/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/imrx/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/imrx/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/imrx/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/imrx/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/imrx/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/imrx/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/imrx/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/imrx/stock-options-outstanding-number https://stock.noler.com/us/stock/imrx/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/imrx/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/imrx/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/imrx/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/imrx/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/imrx/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/imrx/stock-split-ratio https://stock.noler.com/us/stock/imrx/stock-splits https://stock.noler.com/us/stock/imrx/sublease-income https://stock.noler.com/us/stock/imrx/subsidiaries https://stock.noler.com/us/stock/imrx/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/imrx/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/imrx/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/imrx/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/imrx/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/imrx/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/imrx/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/imrx/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/imrx/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/imrx/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/imrx/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/imrx/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/imrx/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/imrx/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/imrx/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/imrx/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/imrx/total-assets https://stock.noler.com/us/stock/imrx/total-liabilities https://stock.noler.com/us/stock/imrx/total-liabilities-and-equity https://stock.noler.com/us/stock/imrx/unrecognized-tax-benefits https://stock.noler.com/us/stock/imrx/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/imrx/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/imrx/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/imrx/variable-lease-cost https://stock.noler.com/us/stock/imrx/warrants-and-rights-outstanding